| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Neuroscience and Cell Biology, The University of Texas Medical Branch, Galveston, Texas 77555-1069
Submitted 2 April 2004; accepted in final form 9 June 2004
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
; Neugebauer et al. 1996; Satoh et al. 1992; Sun et al. 2003a, b), where it is found in the terminals of unmyelinated (C) and thinly myelinated (A
) afferent fibers (see review by Willis and Coggeshall 2004). CGRP can enhance the release of glutamate and aspartate in the spinal cord (Kangrga and Randic 1990; Smullin et al. 1990), increase the responses of WDR and nociceptive specific neurons to N-methyl-D-aspartate (NMDA) or (R,S)-
-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) (Ebersberger et al. 2000), and facilitate the actions of substance P in behavioral and electrophysiological experiments by potentiating the release and inhibiting the degradation of substance P (Biella et al. 1991; LeGreves et al. 1985; Mao et al. 1992a; Oku et al. 1987; Schaible et al. 1992; Wiesenfeld-Hallin et al. 1984; Woolf and Wiesen-Hallin 1986). Together, these studies suggest that CGRP may produce its effect on pain transmission and modulation through interactions with substance P and excitatory amino acids. Alternatively, CGRP may be involved in pain transmission independently of substance P and excitatory amino acids. It has been reported that CGRP itself produces a depolarization (Miletic and Tan 1988; Ryu et al. 1988). Our previous studies demonstrated that the effects of CGRP in hyperalgesia and central sensitization are mediated by CGRP1 receptors (Sun et al. 2003a, b). The CGRP receptor is considered to be a protein formed by a complex of seven transmembrane domains and includes a calcitonin receptor-like receptor (CRLR), a receptor activity-modifying protein (RAMP) that defines the relative potency of ligands for the receptor, and a receptor component protein (RCP) that defines the G protein to which the receptor couples (Chakravarty et al. 2000; Evans et al. 2000; McLatchie et al. 1998). The CGRP1 receptor, which binds CGRP and CGRP8–37 with highest affinity, is made up of CRLR, RAMP1, and RCP, which couples the CGRP receptor to cellular signal transduction machinery (McLatchie et al. 1998). Among the second messengers produced by CGRP receptor activation is cAMP and its down-stream protein kinase A (PKA) (Baidan et al. 1992; Parsons and Seybold 1997; Parameswaran et al. 2000; Poyner 1992; Seybold et al. 2003). However, little is known regarding the signaling molecules and the second-messenger pathways involved in CGRP-mediated secondary hyperalgesia and central sensitization. In this study, we first found that the PKA inhibitor H89 could prevent the hyperalgesia and the sensitization of WDR neurons induced by CGRP. Considering that CGRP also stimulated phosphoinositide turnover and a Ca2+-signaling pathway (Aiyar et al. 1999; Laufer and Changeux 1989) and that protein kinase C (PKC) is involved in the development of central sensitization and nociceptive transmission, we tested whether the PKC pathway is also the downstream of CGRP receptor activation. Our behavioral and electrophysiological results showed that inhibition of PKA and PKC blocked the mechanical hyperalgesia and central sensitization induced by CGRP. |
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Male Sprague-Dawley rats weighing 270–320 g were used in this study. The experiments were approved by the Institutional Animal Care and Use Committee and were consistent with the ethical guidelines of the National Institutes of Health and of the International Association for the Study of Pain.
All experimental animals were housed and maintained in accordance with the guidelines of the University of Texas Medical Branch Animal Care and Use Committee.
Placement of intrathecal catheters for behavioral experiments
Externally accessible PE-10 intrathecal catheters were implanted in rats to be used for behavioral testing according to a modification of the technique described by Storkson et al. (1996). After anesthesia with pentobarbital sodium (50 mg/kg ip), a catheter (PE 10, 0.61 mm OD) was inserted into the subarachnoid space through a guide cannula connected to a 20-gauge needle, which punctured the dura at the level of the cauda equina. The catheter was then carefully implanted rostrally, aiming its tip just dorsal to the lumbar enlargement. The position of the catheter was checked postmortem.
General preparation and anesthesia in electrophysiological experiments
Rats were anesthetized initially with pentobarbital sodium (50 mg/kg ip) for performing surgery. The trachea was cannulated to provide unobstructed ventilation, and a catheter was inserted into the external jugular vein for maintenance of anesthesia during experiment by continuous infusion of sodium pentobarbital (10 mg · kg–1 · h–1). The level of anesthesia was frequently checked during the experiment by examining corneal and withdrawal reflexes and observation of end-tidal CO2 level. Once a stable level of surgical anesthesia was reached, the animals were paralyzed with an initial dose of pancuronium (1 mg/kg), and they were ventilated artificially to maintain the end-tidal CO2 between 3.5 and 4.5%. Paralysis of the musculature was maintained by continuous infusion of pancuronium (0.4–0.6 mg · kg–1 · h–1). A laminectomy was performed to expose the spinal cord at the T13–L2 vertebral level. The spinal cord was continually bathed in a pool of warm (37°C) mineral oil except for those spinal segments to be superfused. Core body temperature was maintained at 37°C by a servo-controlled heating blanket.
Administration of drugs
CGRP8–37 (Sigma), CGRP (TOCRIS), and H89 (an inhibitor of PKA, Calbiochem) were dissolved in artificial cerebrospinal fluid (ACSF), and chelerythrine chloride (CC, an inhibitor of PKC, Calbiochem) was dissolved in 0.2% DMSO. In behavioral experiments, drugs were administered by intrathecal injection. In electrophysiological experiments, drugs were applied by controlled superfusion of the spinal cord at the segments from which recordings were made. A specially synthesized silicone rubber was used to form a small well on the cord dorsum at the recording level for controlled superfusion of the spinal cord (Beck et al. 1995). H89 or CC was applied in the silicone well after control responses were recorded. Thirty minutes later, H89 or CC was removed, and CGRP was applied in the well. Thirty minutes after that, the responses were measured to test whether the effect produced by CGRP would be blocked by H89 or CC. Then ACSF was used several times to wash out CGRP left on the cord. Thirty minutes later, the responses were measured again.
Behavioral testing
Animals were tested for responses to von Frey filament (Stoelting) application. Animals were placed in plastic cages on an elevated screen and allowed to acclimate to the testing environment for 30 min. The 50% paw withdrawal threshold in response to von Frey hair probing was detected using the up-down method (Chaplan et al. 1994). Beginning with the 2.00 g filament, which is in the middle of the series of eight von Frey filaments (0.41, 0.70, 1.20, 2.00, 3.63, 5.50, 8.50, and 15.10 g) with logarithmically incremental stiffness ranging from 0.41 to 15.1 g (numbers 3.61–5.18), each filament was applied with enough force to cause slight bending and this force was held for 
6–8 s. A positive response was recorded if the paw was sharply withdrawn. The pattern of positive and negative responses was converted to a 50% threshold value by using the formula given by Dixon (1980). The observer was blinded to the treatment of rats.
Recording from wide dynamic range neurons
Recordings were made from wide dynamic range (WDR) neurons in the dorsal horn. These neurons responded to both innocuous and noxious mechanical stimulation, but best to noxious stimuli. Cells were searched for under the small well for controlled superfusion of the spinal cord at the L5 segment using low-impedance (3–5 M
) carbon filament electrodes (Kation Scientific, Minneapolis, MN) and an electronic micromanipulator that advanced in 5-µm steps. Search stimuli consisted of mechanical stimulation (innocuous stimuli consisted of brushing in a stereotyped manner with a camel's hair brush, noxious stimuli were mild pinching with the experimenter's fingers). WDR neurons with receptive fields (RFs) located on the plantar surface of the hindpaw were recorded extracellularly in the L5 segment of the spinal cord. Data were analyzed only from recordings of the activity of single neurons the spike amplitude of which could be easily discriminated from spikes of neighboring units. Electrophysiological activity was amplified and displayed on a storage oscilloscope before being sent to a data analysis system (CED 1401, PC) for data collection using Spike-2 software, which enables computation and storage of peristimulus rate histograms. Throughout the experiment, spike size and configuration were continuously monitored on the digital oscilloscope and with the use of Spike-2 software to confirm that the same WDR neuron was recorded and that the relationship of the recording electrode to the neuron remained constant.
Evoked response measures and experimental design
After the RF of the identified WDR neuron was mapped using brush and mild pinch stimuli, graded mechanical stimuli were applied. These consisted of brushing the skin with a camel hair brush in a stereotyped manner (20 strokes/10 s), and then sustained application of an arterial clip to a fold of skin. The clip produced a sensation of firm pressure (press, 144 g/mm2) near the threshold for pain when applied to human skin. The background activity was recorded for 5 min before the application of the mechanical stimuli. Each stimulus (brush, press) was applied for 10 s followed by a 2-min pause. Responses to mechanical stimuli were calculated by subtracting the mean background discharge from the total activity that occurred during the 10-s stimulus. Three baseline responses were determined for brush and pressure, and an average response was calculated as baseline. To minimize a potential "human factor" bias, the experimenter who applied the mechanical stimuli did not observe the oscilloscope or the computer monitor and was unaware of the response magnitude.
Statistical analysis
In electrophysiological experiments, the baseline activity (background activity and responses to brush and press) was regarded as control (100%) in each group. The activity of each WDR neuron after drug or ACSF administration was expressed as a percentage of baseline. Values are presented as means ± SE. Comparison between the means was analyzed with repeated-measures ANOVA followed by Newman-Keuls test. In all tests, significance was accepted at the level P < 0.05.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
H89 INHIBITS THE EFFECT OF CGRP.
To test whether the effect of CGRP (0.5 µM, 10 µl) on nociception was dependent on the PKA second-messenger system, H89 (10 µM, 10 µl) was given 20 min before CGRP application. As a control for the effect of H89 or CGRP, the same volume of ACSF was used. Thirty rats were divided into five groups randomly. The groups were ACSF+ACSF, H89+ACSF, ACSF+CGRP, ACSF+CGRP+CGRP8–37, and H89+CGRP. H89 (10 µM, 10 µl) was given 20 min before CGRP (0.5 µM, 10 µl) application. As shown in Fig. 1, there was no significant difference among 50% mechanical thresholds at any time point after injection of ACSF, i.e., 5, 10, 30, 50, 70, and 90 min. H89 given alone did not alter the baseline mechanical threshold, which was consistent with a previous report (Sluka and Willis 1997). After injection of CGRP (0.5 µM, 10 µl), 50% paw withdrawal threshold decreased significantly. The decrease in the 50% paw withdrawal threshold was maintained for 
50 min after injection of CGRP and peaked at or before 30 min (Fig. 1A). CGRP8–37 (10 µM, 5 µl) blocked the effect of CGRP (1 µM, 5 µl; the mean 50% paw withdrawal threshold in the CGRP+ CGRP8-37 group was 14.03 ± 0.52 g), which was consistent with previous results (Sun et al. 2003b). Application of H89 before CGRP completely blocked CGRP-induced mechanical hyperalgesia (Fig. 1). These results suggest that the effect of CGRP receptor activation in nociception is dependent on the PKA pathway.
|
). After injection of CGRP (0.5 µM, 10 µl), 50% paw withdrawal threshold decreased significantly. The decrease of 50% paw withdrawal threshold was maintained for 50 min after injection of CGRP (Fig. 2). Application of CC before CGRP completely blocked CGRP-induced mechanical hyperalgesia (Fig. 2). This result suggests that the effect of CGRP in nociception is also dependent on the PKC pathway.
|
In 36 rats, neurons with afferent input from the plantar surface of the hindpaw were recorded in segment L5 of the spinal cord at depths of 260–800 µm from the cord dorsum. Three neurons were located at depths of 260–320 µm, 8 at 320–500 µm, and 25 at 500–800 µm. Most neurons in the sample were estimated to be distributed widely in laminae V and VI (500–800 µm). All the recorded neurons were of the WDR type and exhibited spontaneous activity. The activity after drug or ACSF administration is expressed as a percentage of baseline.
The following experiments tested whether blockade of PKA or PKC could prevent the enhancement of the responses of the WDR neurons by CGRP. In two experimental groups, the spinal cord was pretreated with H89 (10 µM, 15 µl) or CC (0.1 mM, 15 µl) before CGRP (0.5 µM, 15 µl) was infused. In a control group, ACSF was applied instead of H89 or CC. To test whether the CGRP 1 receptor antagonist blocks the effect of CGRP, CGRP (1 µM, 7.5 µl) and CGRP8–37 (20 µM, 7.5 µl) were applied together. In another control group, only ACSF was infused.
The activity of a representative WDR neuron in the dorsal horn after application of CGRP is shown by rate histograms in Fig. 3. The top row shows the baseline background activity and responses to brush and press. After the baseline activity was recorded, ACSF was applied, and 30 min later CGRP was administered. There was no difference between the baseline activity (Fig. 3, top) and the activity 30 min after ACSF superfusion (2nd row). However, 30 min after superfusion of CGRP, the representative WDR neuron showed an increase in background activity and in responses to press but not in responses to brush (Fig. 3, 3rd row) compared with the baseline activity (Fig. 3, top). Furthermore, the increases in background activity and in responses to press outlasted the drug infusion period for more than half an hour (Fig. 3, bottom). After CGRP superfusion, neurons were considered responsive to CGRP when changes in background activity and responses to mechanical stimuli were increased >25% from baseline value. According to this criterion, in three of six WDR neurons tested, there was an increase in background activity after CGRP superfusion. A summary of the grouped data is shown in Fig. 4. At 30 min after superfusion with ACSF (15 µl), there were no significant changes in the background activity and responses to mechanical stimuli of naïve WDR neurons. At 30 min after superfusion of CGRP (0.5 µM, 15 µl), responses to press significantly increased to 160.1 ± 7.5% (repeated-measures ANOVA followed by Newman-Keuls test, P < 0.05), but the responses to brush stimuli were not obviously changed. Moreover, after washout, the increases in responses to press induced by CGRP lasted at least half an hour. Because CGRP produced inconsistent effects on the background activity of neurons, background activity was not significantly increased. At 30 min after superfusion of CGRP (1 µM, 7.5 µl) + CGRP8-37 (20 µM, 7.5 µl), the background activity and responses to brush and press of WDR neurons was 113.1 ± 9.6, 94.5 ± 8.5, and 106.9 ± 12.8% of baseline, respectively. CGRP8–37 attenuated the effect of CGRP completely, consistent with our previous study (unpublished details). There were no significant changes in the responses of the WDR neurons at 30, 60, and 90 min after ACSF compared with baseline. Figure 5A contains rate histograms of a representative WDR neuron that showed a blockade of CGRP-induced enhancement by H89. H89 pretreatment itself produced no significant changes in the background activity or in responses to brush or press stimuli (middle). However, the enhanced response to noxious mechanical stimuli produced by CGRP superfusion was nearly completely blocked (bottom). A PKC inhibitor, CC, also blocked the enhanced responses induced by CGRP. Figure 5B shows a typical experiment on one WDR neuron. The grouped data are summarized in Fig. 6.
|
|
|
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Our previous behavioral and electrophysiological studies demonstrated that activation of CGRP 1 receptors in the dorsal horn contributes to the development of central sensitization associated with cutaneous inflammation (Sun et al. 2003a, b). PKA and PKC have both been shown to be involved in the establishment and/or maintenance of central sensitization (Ji and Woolf 2001; Lin et al. 1996, 2002; Willis 2001a, b). Several lines of evidence point to an important role of PKA in pain transmission: a dose-dependent hyperalgesia and allodynia can be induced when the spinal dorsal horn is perfused with 8-bromo-cAMP, a PKA activator (Sluka 1997). Activation of PKA increases the responses of spinothalamic tract (STT) to mechanical stimuli (Lin et al. 2002). Activation of PKA causes NMDA receptors to be phosphorylated (Zou et al. 2002) in the dorsal horn, including on STT cells, and modulates A-type K+ current and neuron excitability (Hu and Gereau 2003; Hu et al. 2003). Ample evidence also supports a critical role of PKC in pain modulation. It has been shown that the level of membrane bound PKC is increased in dorsal horn neurons after noxious stimuli (Mao et al. 1992b; Yashpal et al. 1995). Electrophysiological experiments have shown that PKC activation modulates A-type K+ current and neuron excitability and leads to an enhanced responsiveness of STT and dorsal horn neurons to mechanical stimuli (Hu and Gereau 2003; Hu et al. 2003; Lin et al. 1996; Palecek et al. 1994; Peng et al. 1997). On the other hand, inhibitors of PKC prevent the sensitization of STT neurons after capsaicin injection. (Sluka et al. 1997). In behavioral studies, PKC inhibitors reversed the mechanical allodynia induced by capsaicin and activation of PKC induced mechanical and thermal hyperalgesia (Palecek et al. 1999; Sluka and Willis 1997). Very little is known about the mechanisms and the cellular signaling pathways by which CGRP produces its effect on neurons in the dorsal horn. A previous study has demonstrated an increased production of cAMP after CGRP stimulation at concentrations of <1 µM in primary cultures of neonatal rat spinal cord (Parsons and Seybold 1997). Moreover, CGRP increases the expression of NK1 receptors by a cAMP-dependent pathway (Seybold et al. 2003). CGRP also leads to extracellular-signal-regulated kinase (ERK) activation by a PKA-dependent pathway (Parameswaran et al. 2000), and ERK contributes to the establishment and maintenance of persistent inflammatory heat and mechanical hypersensitivity (Ji et al. 2003). All the results concerning the signaling pathway downstream of CGRP receptor activation were obtained from in vitro studies. A possible mechanism by which CGRP exerts its effect on dorsal horn neurons is through activation of cAMP and its downstream PKA (Baidan et al. 1992; Parsons and Seybold 1997; Parameswaran et al. 2000; Poyner 1992; Seybold et al. 2003), a signal transduction mechanism well known to contribute to the sensitization of STT neurons (Lin et al. 2002; Sluka et al. 1997). In this study, our behavioral and electrophysiological results showed that not only inhibition of PKA, but also of PKC, blocked the mechanical hyperalgesia and central sensitization induced by CGRP.
Intrathecal inhibitors of spinal PKA, PKC
Intrathecal injection of H89, a PKA inhibitor, or CC, a PKC inhibitor, did not produce a change in mechanical paw withdrawal threshold. However, when either H89 or CC was given intrathecally 20 min before CGRP was delivered, the inhibitor blocked the mechanical hyperalgesia induced by CGRP. These results suggest that the decreased nociceptive threshold induced by CGRP may be mediated by the activation of PKA or PKC.
An important issue is whether the effects of H89 or chelerythrine in fact reflect their actions as PKA or PKC inhibitors. First, the inhibitors of PKA (H89) and PKC (CC) were used at a specific dose chosen based on the results of other comparable studies (Begon et al. 2001; Granados-Soto et al. 2000; Guo et al. 2002; Li and Chen 2003; Seybold et al. 2003; Sluka and Willis 1997; Sluka et al. 1997; Zou et al. 2002; X. Zou and W. D. Willis, unpublished data) and known to target these pathways selectively. Second, the IC50 of H89 for PKA is 48 nM, for PKG is 480 nM, and for PKC is 31.7 µM (Chijiwa et al. 1990). Previous studies showed that H89 at a dose of 10 µM inhibited PKA selectively but did not inhibit PKG (Lin et al. 2002; Sluka et al. 1997). Because the IC50 of H89 for PKC is very much higher than that for PKG, we think that 10 µM H89, which did not inhibit PKG, must not inhibit PKC. CC has a high selectivity for PKC (i.e., IC50 for PKC is 0.66 µM and for PKA 170 µM) (Granados-Soto et al. 2000; Herbert et al. 1990). However, we cannot rule out the contribution of other protein kinases to this effect. In this study, the drugs were applied topically onto the cord dorsum, and therefore a smaller concentration of the drugs will reach neurons embedded deep in the dorsal horn. This makes CC and H89 less likely to affect other protein kinases. Third, the effects of H89 or CC were observed at doses that did not affect the baseline nociceptive threshold or motor function (Granados-Soto et al. 2000). Our data from experiments using inhibitors of PKA and PKC suggest that CGRP-evoked hyperalgesia is mediated by the PKA as well as the PKC second-messenger systems because PKA and PKC inhibitors significantly attenuated the mechanical hyperalgesia induced by CGRP receptor activation. The electrophysiological results showed that the increased responses of WDR neurons in the dorsal horn to noxious stimuli produced by CGRP were blocked by H89 and significantly attenuated by chelerythrine. The results of the electrophysiological experiments on dorsal horn neurons are consistent with the behavioral data and suggest a direct action of CGRP, H89, and CC on spinal sensory neurons.
Are PKA and PKC activated directly or indirectly?
In this study, we found that the effects of CGRP are significantly blocked by a PKA or PKC inhibitor. It appears that both PKA and PKC are necessary for the effects of CGRP. Is there a cross-talk between PKA and PKC? Indeed, in skeletal muscle, CGRP was shown to stimulate phosphoinositide turnover, most likely through the CGRP-induced increase in levels of cAMP as this effect was mimicked by other cAMP-mobilizing agents such as forskolin (Laufer and Changeux 1989). In a similar fashion, CGRP was reported to increase intracellular cAMP levels in human ocular ciliary epithelial cells (Crook and Yabu 1992). This increase was apparently modulated by PKC because the interaction of the latter with CGRP receptors prevented a further increase in cAMP levels. This suggests that both the PKA and PKC pathways may be downstream of CGRP receptor activation. The activation of multiple intracellular pathways might be due to coupling of CGRP receptors to different transduction mechanisms or to a close interaction between different second-messenger pathways. In fact, several studies have indicated that the PKC and PKA pathways do not function in isolation but rather interact in an intricate intracellular network to achieve the obtained response (Choi and Toscano 1988; Kubota et al. 2003; Sugita et al. 1997). Furthermore, co-activation of PKA and PKC pathways is also triggered by activation of other receptors. For example, co-activation of PKA and PKC is necessary for the effects of prostaglandin E2 (Ren et al. 1996), estrogen (Kelly et al. 1999), 
-adrenergic (Khasar et al. 1999), and bradykinin receptor activation (Kohno et al. 2003). Unfortunately, we cannot deduce whether these pathways are being activated in parallel or in a certain sequence as a result of CGRP receptor activation because of the experimental design in our study. Further examination of these mechanisms would be necessary in future studies.
There is also the possibility that the effect of the PKC inhibitor could reflect an indirect effect of CGRP in this study. Previous studies demonstrated that CGRP receptors are coupled predominantly to adenylyl cyclase via a G protein to induce the formation of cAMP (Poyner 1992, review; Parsons and Seybold 1997). However, NK1 receptors and group I mGluRs are linked with phospholipase C. Activation of NK1 receptors and group I mGluRs leads to generation of diacylglycerol (DAG) and inositol 1,4,5-triphosphate, and DAG is an important factor regulating the activity of PKC (Yokota et al. 1989; Hershey and Krause 1990; Conn and Pin 1997). CGRP can potentiate the release of substance P and glutamate from rat spinal dorsal horn neurons during mechanical nociception, suggesting the presence of presynaptic CGRP receptors on substance P and glutamate neurons (Kangrga and Randic 1990; Oku et al. 1987). In this situation, the PKA pathway may be triggered by activation of presynaptic CGRP receptors on substance P and glutamate neurons, and the PKC pathway may be triggered by SP activation of neurokinin receptors or glutamate activation of metabotropic receptors (Wajima et al. 2000).
However, we cannot exclude the possibility that the effect of CGRP is postsynaptic. Several studies agree that CGRP can produce depolarization of neurons in spinal dorsal horn slices (Miletic and Tan 1988; Ryu et al. 1988). Pre- and postsynaptic CGRP receptors have been localized in the spinal cord (Ye et al. 1999). Thus the effect of CGRP could be pre- or postsynaptic or both. We hypothesize that central sensitization induced by CGRP depends on a cascade or a combination of crucial events in the neurons. Each of these steps may depend on the action of specific receptor and signaling pathway. This suggests that different second-messenger pathways must be co-activated in a coordinated fashion. In this study, both PKA and PKC inhibitors have been shown to block the effect of CGRP in mechanical hyperalgesia and central sensitization.
In conclusion, our data suggest that activation of CGRP receptors in the spinal cord produces mechanical hyperalgesia and sensitizes WDR neurons in the dorsal horn in the rat. These effects of CGRP are mediated by at least two second-messenger systems involving PKA and PKC.
|
GRANTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: W. D. Willis, Dept. of Neuroscience and Cell Biology, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1069 (E-mail: wdwillis{at}utmb.edu).
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Baidan LV, Fertel RH, and Wood JD. Effects of brain-gut related peptide on cAMP levels in myenteric ganglia of guinea pig small intestine. Eur J Pharmacol 255: 21–27, 1992.
Beck H, Schrock H, and Sandkuhler J. Controlled superfusion of the rat spinal cord for studying non-synaptic transmission: an autoradiographic analysis. J Neurosci Methods 58: 193–202, 1995.[CrossRef][ISI][Medline]
Begon S, Pickering G, Eschalier A, Mazur A, Rayssiguier Y, and Dubray C. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats. Br J Pharmacol 134: 1227–1236, 2001.[ISI][Medline]
Bennett AD, Chastain KM, and Hulsebosch CE. Alleviation of mechanical and thermal allodynia by CGRP 8–37 in a rodent model of chronic central pain. Pain 86: 163–175, 2000.[CrossRef][ISI][Medline]
Biella G, Panara C, Pecile A, and Sotgiu ML. Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo. Brain Res 559: 352–356, 1991.[CrossRef][ISI][Medline]
Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, and Smith DM. CGRP and adrenomedulli binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPS) in rat tissures. Br J Pharmacol 130: 189–195, 2000.[CrossRef][ISI][Medline]
Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55–63, 1994.[CrossRef][ISI][Medline]
Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, and Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265: 5267–5272, 1990.
Choi EJ and Toscano WA Jr. Modulation of adenylate cyclase in human keratinocytes by protein kinase C. J Biol Chem 263: 17167–17172, 1988.
Conn PJ and Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37: 205–237, 1997.[CrossRef][ISI][Medline]
Crook RB and Yabu JM. Calcitonin gene-related peptide stimulates intracellular cAMP via a protein kinase controlled mechanism in human ocular ciliary epithelial cells. Biochem Biophys Res Commun 188: 662–670, 1992.[CrossRef][ISI][Medline]
Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20: 441–462, 1980.[CrossRef][ISI][Medline]
Ebersberger A, Issa P C, Wanegas H, and Schaible H-G. Differential effects of calcitonin gene-related peptide and calcitonin gene-related peptide 8–37 upon responses to N-methyl-D-aspartate or (R,S)--amino-3-hydroxy-5-methylisoxazole-4-propionate in spinal nociceptive neurons with knee joint input in the rat. Neuroscience 99: 171–178, 2000.[CrossRef][ISI][Medline]
Evans BN, Rosenblatt MI, Mnayers LO, Oliver KR, and Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedulli receptors. J Biol Chem 275: 31438–31443, 2000.
Granados-Soto V, Kalcheva I, Hua X, Newton A, and Yaksh TL. Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain 85: 395–404, 2000.[CrossRef][ISI][Medline]
Guo W, Zou S, Guan Y, Ikeda T, Tal M, Dubner R, and Ren K. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J Neurosci 22: 6208–6207, 2002.
Herbert JM, Augereau JM, Gleye J, and Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993–999, 1990.[CrossRef][ISI][Medline]
Hershey AD and Krause JE. Molecular characterizationof a functional complementary DNA encoding the rat substance P receptor. Science 247: 958–962, 1990.
Hu HJ and Gereau RW IV. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. II. Modulation of neuronal excitability. J Neurophysiol 90: 1680–1688, 2003.
Hu HJ, Glauner KS, and Gereau RW IV. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. I. Modulation of A-type K+ currents. J Neurophysiol 90: 1671–1679, 2003.
Ji RR and Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8: 1–10, 2001.[CrossRef][ISI][Medline]
Ji RR, Kohno T, Moore KA, and Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26: 696–705, 2003.[CrossRef][ISI][Medline]
Kangrga I and Randic M. Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from rat spinal dorsal horn slice. J Neurosci 10: 2026–2038, 1990.[Abstract]
Kelly Martin J, Lagrange AH, Wagner EJ, and Rnnekleiv OK. Rapid effects of estrogen to modulate G-protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64: 64–75, 1999.[CrossRef][ISI][Medline]
Khasar SG, McCarter G, and Levine JD. Epinephrine produces a -adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 81: 1104–1112, 1999.
Kohno T, Wang H, Ito N, Brenner GJ, Ji R, and Woolf CJ. Bradykinin co-activates PKC and PKA in spinal neurons facilitating synaptic transmission and generating pain hypersensitivity. Soc Neurosci Abstr 693.6. 2003.
Kubota H, Katsurabayashi S, Moorhouse A, Murakami N, Koga H, and Akaike N. GABAB receptor transduction mechanisms, and cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons of the rat nucleus basalis of Meynert. J Physiol 551: 263–276, 2003.
Laufer R and Changeux JP. Calcitonin gene-related peptide and cyclic AMP stimulate phosphoinositide turnover in skeletal muscle cells. J Biol Chem 264: 2683–2689, 1989.
LeGreves P, Nyberg F, Terenius L, and Hökfelt T. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol 115: 309–311, 1985.[CrossRef][ISI][Medline]
Li KC and Chen J. Differential roles of spinal protein kinase C and A in development of primary heat and mechanical hypersensitivity induced by subcutaneous bee venom chemical injury in the rat. Neurosignals 12: 292–301, 2003.[CrossRef][ISI][Medline]
Lin Q, Peng YB, and Willis WD. Possible role of protein kinase C in the sensitization of primate spinothalamic tract neurons. J Neurosci 16: 3026–3034, 1996.
Lin Q, Wu J, and Willis WD. Effect of protein kinase A activation on the responses of primate spinothalamic tract neurons to mechanical stimuli. J Neurophysiol 88: 214–221, 2002.
Mao J, Coghill RC, Kellstein DE. Frenk H, and Mayer DJ. Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation. Brain Res 574: 157–163, 1992a.[CrossRef][ISI][Medline]
Mao J, Price DD, Mayer DJ, and Hayes RL. Pain-related increases in spinal cord membrance-bound protein kinase C following peripheral nerve injury. Brain Res 588: 144–149, 1992b.[CrossRef][ISI][Medline]
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. RAMPS regulate the transport and ligand specificity of the calcitonin gene-receptor-like receptor. Nature 39: 333–339, 1998.
Miletic V and Tan H. Iontophoretic application of calcitonin gene-related peptide produces a slow and prolonged excitation of neurons in the cat lumber dorsal horn. Brain Res 446: 169–172, 1988.[CrossRef][ISI][Medline]
Neugebauer V, Rumenapp P, and Schaible HG. Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rat's knee joint and in the generation and maintenance of hyperexcitability of dorsal horn neurons during development of acute inflammation. Neuroscience 71: 1095–1109, 1996.[CrossRef][ISI][Medline]
Oku R, Satoh M, Fujii N, Otaka A, Yajima H, and Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res 403: 350–354, 1987.[CrossRef][ISI][Medline]
Palecek J, Paleckova V, Dougherty PM, and Willis WD. The effect of phorbol esters on the responses of primate spinothalamic neurons to mechanical and thermal stimuli. J Neurophysiol 71: 529–537, 1994.
Palecek J, Paleckova V, and Willis WD. The effect of phorbol esters on spinal cord amino acid concentrations and responsiveness of rats to mechanical and thermal stimuli. Pain 80: 597–605, 1999.[CrossRef][ISI][Medline]
Parameswaran N, Disa J, Spielman WS, Brooks DP, Nambi P, and Aiyar N. Activation of multiple mitogen-activated protein kinases by recombinant calcitonin gene-related peptide receptor. Eur J Pharmacol 389: 125–130, 2000.[CrossRef][ISI][Medline]
Parsons AM and Seybold VS. Calcitonin gene-related peptide induces the formation of second messengers in primary cultures of neonatal rat spinal cord. Synapse 26: 235–242, 1997.[CrossRef][ISI][Medline]
Peng YB, Lin Q, and Willis WD. Involvement of protein kinase C in responses of rat dorsal horn neurons to mechanical stimuli and periaqueductal gray descending inhibition. Exp Brain Res 114: 561–570, 1997.[CrossRef][ISI][Medline]
Poyner DR. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther 56: 32–51, 1992.
Ren J, Karpinski E, and Benishin CG. The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscles cells: regulation by protein kinase A and protein kinase C. J Pharmacol Exp Ther 277: 394–402, 1996.
Ryu PD, Gerber G, Murase K, and Randic M. Actions of calcitonin gene-related peptide on rat spinal dorsal horn neurons. Brain Bes 441: 357–361, 1988.[CrossRef][ISI][Medline]
Satoh M, Kuraishi Y, and Kawamura M. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain 49: 273–278, 1992.[CrossRef][ISI][Medline]
Schaible H-G, Hope PJ, Lang CW, and Duggan AW. Calcitonin gene-related peptide causes intraspinal spreading of substance P released by peripheral stimulation. Eur J Neurosci 4: 750–757, 1992.[CrossRef][ISI][Medline]
Seybold VS, McCarson KE, Mermelstein PG, Groth RD, and Abrahams LG. Calcitonin gene-related peptide regulates expression of neurokinin1 receptors by rat spinal neurons. J Neurosci 23: 1816–1824, 2003.
Sluka KA. Activation of the cAMP transduction cascade contributes to the mechanical hyperalgesia and allodynia induced by acute inflammation. Br J Pharmacol 120: 1263–1273, 1997.[CrossRef][ISI][Medline]
Sluka KA, Rees H, Chen PS, Tsuruoka, and Willis WD. Inhibitors of G-proteins and protein kinases reduced the sensitization to mechanical stimulation and the desensitization to heat of spinothalamic tract neurons induced by intradermal injection of capsaicin in the primate. Exp Brain Res 115: 15–24, 1997.[CrossRef][ISI][Medline]
Sluka KA and Willis WD. The effects of G-protein and protein kinase inhibitors on the behavioral responses of rats to intradermal injection of capsaicin. Pain 71: 165–178, 1997.[CrossRef][ISI][Medline]
Smullin DH, Skilling SR, and Larsson AA. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain 42: 93–101, 1990.[CrossRef][ISI][Medline]
Storkson RV, Kjorsvik A, Tjolsen A, and Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65: 167–172, 1996.[CrossRef][ISI][Medline]
Sugita S, Baxter DA, and Byrne JH. Modulation of cAMP/protein kinase A cascade by protein kinase C in sensory neurons of Aplysia. J Neurosci 17: 7237–7244, 1997.
Sun RQ, Lawand NB, Lin Q, and Willis WD. Capsaicin-induced sensitization of dorsal horn neurons is prevented or reversed by CGRP8-37, a specific CGRP 1 receptor antagonist. Soc Neurosci Abstr 383.9, 2003a.
Sun RQ, Lawand NB, and Willis WD. The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain 104: 201–208, 2003b.[CrossRef][ISI][Medline]
Wajima Z, Hua XY, and Yaksh TL. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia. Brain Res 877: 314–321, 2000.[CrossRef][ISI][Medline]
Wiesenfeld-Hallin Z, Hökfelt T, Lundberg JM, Forssmann WG, Reinecke M, Tschopp FA, and Fischer JA. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett 52: 199–204, 1984.[CrossRef][ISI][Medline]
Willis WD and Coggeshall. Sensory Mechanisms of the Spinal Cord (3rd ed.). New York: Kluver Academic, 2004.
Willis WD. Mechanisms of central sensitization of nociceptive dorsal horn neurons. In: Spinal Cord Plasticity: Alterations in Reflex Function, edited by Patterson MM and Grau JW. New York: Kluver Academic, 2001a, p. 127–161.
Willis WD. Role of neurotransmitters in sensitization of pain responses. Ann NY Acad Sci 933: 142–156, 2001b.[ISI][Medline]
Woolf CJ and Wiesenfeld-Hallin Z. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat. Neurosci Lett 66: 226–230, 1986.[CrossRef][ISI][Medline]
Yashpal K, Pitcher GM, Parent A, Quirion R, and Coderre TJ. Noxious thermal and chemical stimulation induces increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. J Neurosci 15: 3263–3272, 1995.[Abstract]
Ye Z, Wimalawansa SJ, and Westlund KN. Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord. Neuroscience 92: 1389–1397, 1999.[CrossRef][ISI][Medline]
Yokota Y, Sasai Y, Tanaka K, Fujiwara T, Tsuchida K, Shigemoto R, Kakizuka A, Ohkubo H, and Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J Biol Chem 264: 17649–17652, 1989.
Zou X, Lin Q, and Willis WD. Role of protein kinase A in phosphorylation of NMDA receptor 1 subunits in dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats. Neuroscience 115: 775–786, 2002.[CrossRef][ISI][Medline]
This article has been cited by other articles:
|
|
 |
|
  Y. V. Medvedeva, M.-S. Kim, and Y. M. Usachev Mechanisms of Prolonged Presynaptic Ca2+ Signaling and Glutamate Release Induced by TRPV1 Activation in Rat Sensory Neurons J. Neurosci., May 14, 2008; 28(20): 5295 - 5311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Davis, D. Hinerfeld, S. Joseph, Y.-H. Hui, N. H. Huang, J. Leszyk, J. Rutherford-Bethard, and S. W. Tam Proteomic Analysis of Rat Liver Phosphoproteins after Treatment with Protein Kinase Inhibitor H89 (N-(2-[p-Bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide) J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, J. A. McRoberts, H. S. Ennes, M. Trevisani, P. Nicoletti, Y. Mittal, and E. A. Mayer Experimental colitis modulates the functional properties of NMDA receptors in dorsal root ganglia neurons Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G219 - G228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Mogil, F. Miermeister, F. Seifert, K. Strasburg, K. Zimmermann, H. Reinold, J.-S. Austin, N. Bernardini, E. J. Chesler, H. A. Hofmann, et al. Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene PNAS, September 6, 2005; 102(36): 12938 - 12943. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||
